Mary Kay Unveils Breakthrough Research on the Impact of Antioxidants and Vitamin C on Skin Health and Appearance
Mary Kay Inc., a global beauty company and leader in skin care innovation, continues its ongoing support of the beauty and scientific communities by participating in two global dermatological conferences this spring. Mary Kay attended the prestigious Reunión Anual de Dermatólogos Latinoamericanos (RADLA) May 4–7 in Buenos Aires, Argentina, where it presented findings related to the effects of pollution on skin health. The company will also sponsor the 77th Annual Meeting of the Society for Investigative Dermatology (SID) in Chicago, May 8–11, where it will reveal its latest research on how five fruit extracts known to contain vitamin C work to help skin appearance.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190508005528/en/
Lucy Gildea, Chief Scientific Officer at Mary Kay Inc. presenting at RADLA. (Photo: Mary Kay Inc.)
During the 37th annual RADLA conference, leading skin care experts from around the world convened to explore various topics, including the impact of external environmental aggressors on skin health. Mary Kay presented research focused on skin concerns stemming from diesel exhaust particles (DEP) in the environment. Continued exposure to DEP increases free radicals in skin cells, which can ultimately impact premature signs of skin aging, like dark spots and dullness Fortunately, Mary Kay also presented findings on an antioxidant complex that can help delay the premature signs of aging related to the damaging effects of DEP. This breakthrough technology, found in the Mary Kay® TimeWise® Miracle Set 3D™ skin care line, provides a powerful free-radical regimen with an exclusive, patent-pending, three-dimensional approach to skin aging.
“Mary Kay scientists spent years researching the latest ingredient innovations to develop our newest skin care collection that defends against free radicals and helps delay the onset of premature skin aging from unavoidable environmental and lifestyle stressors such as car exhaust and air pollution,” said Dr. Lucy Gildea, Chief Scientific Officer at Mary Kay Inc.
While attending SID this week, Mary Kay Associate Principal Scientist Tiffany Carle will present new data collected while analyzing the effects of a serum containing five botanical fruit extracts known to be rich in vitamin C on skin appearance. As part of this study, Mary Kay researchers treated artificial skin tissue with this serum and utilized a genomic approach to understand how the serum affected the skin. This genomic evaluation revealed involvement of four main classes of genes important for skin firmness. Furthermore, the study showcased that the serum treatment increased production of dermal matrix proteins collagen and laminin that support skin firmness. This study confirms how the serum works to help improve the appearance of skin laxity and texture.
Mary Kay’s Research and Development team is comprised of distinguished scientists who hold doctorates and other advanced degrees across multiple disciplines: skin biology, cell biology, chemistry, biochemistry and more. This team of scientists is dedicated to conducting ongoing breakthrough research and sharing impactful findings related to skin health with the scientific and beauty communities at large.
“Our Research & Development team is committed to developing the technology in our products so we can help improve skin health and provide women across the globe with the skin confidence they deserve,” said Dr. Gildea. “Participating in events like RADLA and SID allows us to learn and share relevant research so we can continue to deliver meaningful benefits and amazing products to consumers.”
Every year, Mary Kay conducts hundreds of thousands of scientific tests on products and ingredients to ensure the highest standards of safety, quality and performance. Mary Kay holds more than 1,500 patents for products, technologies and packaging designs in its global portfolio. Recently, the company announced the opening of a more than $100 million state-of-the-art manufacturing and R&D facility in Lewisville, Texas.
ABOUT MARY KAY
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 55 years ago with three goals: offer rewarding opportunities for women, manufacture irresistible products and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to researching the science behind beauty and to manufacturing cutting-edge skin care, color cosmetics and nutritional supplements. Through the Mary Kay FoundationSM, the company has awarded more than $78 million to cancer research and domestic violence shelters. Mary Kay Ash’s original vision continues to shine—one lipstick at a time.
Mary Kay Inc. Corporate Communications
972.687.5332 or firstname.lastname@example.org
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Enlighted Expands IoT Platform Lighting Control Capabilities20.5.2019 10:00:00 CEST | Pressemelding
Enlighted, the leading provider of Internet of Things (IoT) solutions for commercial buildings and healthcare facilities, today announced new lighting control capabilities have been added to its award-winning building IoT Platform. These include advanced tunable white lighting control, daylight harvesting group capabilities, and a two-wire interface for the company’s powerful sensors. Together these new advancements improve the health and well-being of building occupants, improve lighting aesthetics, simplify fixture integration and reduce costs. Advanced Tunable White Lighting Control Enlighted sensors go beyond the automated circadian rhythm capabilities typically found in today’s tunable white solutions and now provide user-level control of color temperature to desired levels. The color temperature can be automatically aligned with the astronomical clock or directly tuned according to specific user needs. Occupants can tailor their environment, improve productivity and comfort, and
ams, Ibeo and ZF Partner to Deliver Industry-First Solid-State LiDAR Systems for the Automotive Industry20.5.2019 09:36:00 CEST | Pressemelding
ams (SIX: AMS), a leading worldwide supplier of high performance sensor solutions, announces today that it has signed an agreement to team with Ibeo Automotive Systems GmbH, the German specialist for automotive LiDAR sensor technology, and ZF Friedrichshafen AG, one of the leading technology companies for mobility worldwide to advance solid-state LiDAR technology for use in autonomous driving and other applications. The three companies will partner on joint R&D efforts to ensure that this exciting technology can be quickly and safely adopted by 2021. LiDAR is an optical sensing technology that measures distance and direction of the surrounding objects by illuminating them with a laser beam and detecting the reflection of the object. Its unique range and resolution properties complement radar and camera solutions to enable the ‘Holy Grail’ of the self-driving car industry – SAE level 5* or fully autonomous driving. ams will provide automotive-grade VCSEL (Vertical Cavity Surface Emittin
Personalis, Inc. to Present at Advances in Immuno-Oncology Congress UK 201920.5.2019 07:05:00 CEST | Pressemelding
Personalis, Inc., a leader in advanced genomics for cancer, today announced that the company will present at Advances in Immuno-Oncology Congress UK 2019 in London on May 21st at 11:00 AM BST. The presentation, entitled “Advancing Precision Oncology Biomarker Discovery with a Multi-dimensional Immunogenomics Platform,” will introduce Personalis’ new universal cancer immunogenomics platform, ImmunoID NeXT™. In addition to an overview, the presentation will introduce preliminary data from an ongoing study in which this platform is being used to evaluate IO-related biomarkers and potential tumor escape mechanisms in a cohort of melanoma patients treated with anti-PD-1 therapy. ImmunoID NeXT™ is the first platform to provide comprehensive analysis of both a tumor and its immune microenvironment from a single sample. The platform can be used to investigate the key tumor- and immune-related areas of cancer biology, consolidating multiple oncology biomarker assays into one. This maximizes the
New Study Evaluates Ability of Masimo SpHb® (Noninvasive Hemoglobin) to Estimate Timing for Invasive Measurement to Detect Anemia During Surgery20.5.2019 07:00:00 CEST | Pressemelding
Masimo (NASDAQ: MASI) announced today the results of a study published in BMC Anesthesiology in which clinicians at Peking Union Medical College in Beijing evaluated the ability of noninvasive and continuous hemoglobin monitoring with Masimo SpHb® to help clincians estimate when to conduct invasive hemoglobin measurement to detect possible anemia in patients undergoing spine or cytoreductive surgery.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190520005244/en/ Masimo Radical-7® with SpHb® (Photo: Business Wire) Noting that because of the “invasive, time-consuming and intermittent” nature of invasive blood sampling, clincians often forgo these “objective indications” when making transfusion decisions during surgery, Dr. Tang and colleagues sought to determine whether noninvasive, continuous hemoglobin monitoring could aid clinicians in estimating when it might be appropriate to perform an invasive measurement. They enroll
Cleo to Showcase End-to-End Approach to Ecosystem Integration at Gartner AADI in London20.5.2019 07:00:00 CEST | Pressemelding
Gartner’s Application Architecture, Development & Integration (AADI) Summit returns to London to provide strategies for solving the pervasive challenges of orchestrating workflows between external B2B and application ecosystems with internal business systems. Cleo, the global leader in ecosystem integration solutions, will be exhibiting in Booth S3 to demonstrate how successful organisations leverage its “outside-in” approach to create seamless end-to-end workflows and help optimize business processes. The Gartner AADI 2019 event, taking place 20-21 May at Park Plaza Westminster, is designed to empower IT and business professionals in transforming their application architecture, agile development, and integration strategies. The event’s focus on application strategies and data processes in the era of the cloud highlights the need for better ways to execute application integration, an inescapable challenge in today’s business landscape. According to the 2019 State of Ecosystem and Integ
Commerzbank Partners with GTC to Further Digitize and Automate its Trade Finance Business20.5.2019 04:00:00 CEST | Pressemelding
Commerzbank has entered into a strategic partnership with GlobalTrade Corporation (GTC), a leading Canadian application services provider of innovative multi-bank trade finance solutions. The bank plans to utilise GTC’s @GlobalTrade™ platform to strengthen its digital trade finance product range. As one of Europe’s leading trade finance banks, Commerzbank holds the digitalisation and automation of processes as key priorities. This partnership leverages Commerzbank’s unique network footprint and GTC’s multi-bank technology, coupled with SWIFT connectivity, to meet the trade finance needs of corporate clients across the globe more efficiently and effectively. “We are very pleased to have found a strategic and reliable business partner in the trade finance business in GTC. Together we will provide digital, multi-bank trade finance solutions to our clients as well as an expanded range of trade products,” said Klaus Josef Müller, Head of Trade Finance and Cash Management Product Management